Related Experiment Video
Updated: Jan 31, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Circulating Exosomes as Potential Biomarkers in Cardiovascular Disease
Seyed Mostafa Parizadeh1, Reza Jafarzadeh-Esfehani2, Maryam Ghandehari1,3
1Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Cardiovascular disease (CVD) biomarkers are evolving with circulating exosomes. Further research is needed to understand exosome profiles, like miRNAs, for diagnosing conditions such as myocardial injury.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiology
Background:
- Cardiovascular disease (CVD) remains a leading cause of death globally.
- Circulating exosomes are emerging as key extracellular transporters in biological fluids.
- Exosomes offer a novel avenue for disease diagnostics, particularly for CVD.
Purpose of the Study:
- To review the role of exosomes as potential biomarkers for CVD.
- To highlight recent advancements in exosome isolation, detection, and characterization methods.
- To emphasize the need for further studies on exosome profiles, including miRNAs, in conditions like myocardial injury.
Main Methods:
- Literature review focusing on exosome research in cardiovascular disease.
- Analysis of current methodologies for exosome isolation and purification from biological fluids.
- Examination of techniques for exosome detection and characterization, including nanoparticle tracking analysis and western blotting.
- Discussion of miRNA profiling within exosomes.
Main Results:
- Circulating exosomes can be isolated and characterized from various biofluids.
- Exosome content, particularly miRNAs, reflects the physiological state of the originating cell.
- Specific exosome profiles show potential for early detection and monitoring of CVD and myocardial injury.
- Advances in isolation and detection methods are improving the reliability of exosome analysis.
Conclusions:
- Exosomes represent a promising, non-invasive biomarker source for CVD.
- Further research is crucial to establish standardized methods for exosome analysis and clinical application.
- Understanding exosome profiles, including specific miRNA signatures, will enhance CVD diagnosis and management.
- Exosomes are poised to revolutionize the diagnostic landscape for cardiovascular conditions.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Overview of the Cardiovascular System
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Fetal Circulation
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...

